| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C26H25NO |
| Molar mass | 367.492 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
NE-CHMIMO (CHM-018) is anindole-basedsynthetic cannabinoid that is presumed to be a potentagonist of theCB1 receptor and has been sold online as adesigner drug.[1][2][3] NE-CHMIMO is the 1-cyclohexylmethyl (instead of 1-pentyl) analogue of the first-generationsynthetic cannabinoidJWH-018. The corresponding cyclohexylmethyl derivative ofJWH-081 had also been reported several months earlier.[4]
In the United States, all CB1 receptor agonists of the 3-(1-naphthoyl)indole class such as NE-CHMIMO areSchedule I Controlled Substances.[5]
NE-CHMIMO is a controlled substance in Japan as of November 2019.[6]
Thiscannabinoid related article is astub. You can help Wikipedia byexpanding it. |